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The purpose of this paper is to provide the reader with an overview of the biomedical and
epidemiological characteristics of asbestos-related disease based upon currently available infor-
mation. Epidemiological and experimental data developed over the past 20 years have greatly
added to our knowledge of the biological effects of asbestos, particularly in relation to clinical
disease. This information has substantially strengthened the evidence linking asbestos to specific
health effects.
Lung cancer and mesothelioma are clearly the most important asbestos-related causes ofdeath
among exposed individuals, although the accumulated data is suggestive of the existence of an
excess risk of gastrointestinal and a variety of other neoplasms. Animal studies confirm the
human epidemiological results and indicate that all commercially available fiber types are
capable of producing lung cancer and mesothelioma. Experimental implantation and injection
studies also show that the carcinogenicity ofmineral fibers (including asbestos) is directly related
to their dimensionality and not their chemical composition.
Although the absestos-related medical and scientific literature is voluminous, many issues
related to the biological activity ofasbestos fibers are as yet unresolved. Due to experimental and
analytical limitations, questions concerning risk at low-level exposure, dose-response relation-
ships, and individual susceptibility remain problematic.
HISTORICAL BACKGROUND
Although the twentieth century has been the setting for much ofthe controversy and
intrigue surrounding exposure to asbestos, fibrous asbestos minerals have long been
used by man. Pottery, dating from the stone age, exhumed in the region ranging from
southern Sudan to northern Kenya has been found to contain amphibole asbestos
fibers. Archeological studies in Finland have also provided evidence that asbestos was
incorporated into pottery by 2500 B.C. [1] Pausanias, the early Greek geographer,
wrote of lamps made during the fifth century B.C. with incombustible wicks, while the
Romans used asbestos cloths to contain the ashes ofnobility during cremation [2]. An
often-recounted story tells of an asbestos table cloth owned by the French emperor,
Charlemagne. In order to impress guests and enemies alike, he would throw the table
cloth into the fire to clean it and recover it unharmed.
From these rather humble and curious beginnings, a Middle Age oddity developed
into a major industrial giant during the nineteenth and twentieth centuries. With the
rediscovery and development oflarge deposits ofasbestos in Canada and South Africa,
commercial exploitation ofthis commodity became a reality. An initial stimulus to the
genesis of the asbestos industry was provided by the industrial revolution of the late
nineteenth century. The development ofmachines for the production and use ofpower
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brought with it the need for packing and insulation [3]. Although the post-industrial
revolution period was the setting for the early manufacture ofasbestos products, it was
not until the advent of World War II that the creation of many new and innovative
asbestos products occurred. Subsequent decades continued to spawn fresh ideas for
practical applications, ranging from filters for the wine industry to plastics, paints, and
asphalt. With markets for asbestos products rapidly expanding, U.S. production levels
soared to well over one hundred thousand tons per year in the early 1930s, accounting
for approximately 3.3 percent of the world figure [2].
Although exposure to natural sources of asbestos fibers in air and water is
unavoidable, the greatest health risk to man is undoubtedly posed by the large-scale
commercialization of this mineral. Nonetheless, the pathogenicity, or at least potential
pathogenicity, of asbestos has been recognized and recorded for decades. In fact, the
historical record extends back to Pliny the Younger (61-114 A.D.), who is said to have
observed a correlation between sickness and asbestos exposure among slaves [3]. It
appears, though, that neither this observation nor many others relating occupational
hazards and disease were matters of concern until relatively recent times.
A number of"hallmark" observations concerning the potential pathologic nature of
asbestos were made during the early part ofthis century. Anderson, in 1898, published
a report indicating that asbestos fiber inhalation in occupational settings is injurious to
the bronchial tubes and lungs [4]. Although neither mortality data nor clinical
follow-up information were provided, this paper represents one ofthe initial reports of
asbestos-related disease in the workplace. It also served to point out that clinical
latency ofthe resulting pulmonary disease represented a major obstacle toestablishing
a stronger association between work with asbestos fibers and adverse health affects.
Murray, in 1907, reported a death due to pulmonary fibrosis in an asbestos textile
worker without tuberculosis [4]. Autopsy showed fibrosis of the lungs and asbestos
fibers in lung tissue. Almost two decades later, in 1924, Cooke [5] originated the term
"asbestosis" in describing the clinical condition of female asbestos workers who had
died from pulmonary fibrosis similar to that seen by Murray in 1907. In this report,
Cooke also cited experimental pathology studies indicating that asbestos dust causes
fibrosis in the lungs of guinea pigs [4]. Shortly thereafter, in 1927, the first major
reviews of asbestosis were published by Cooke, McDonald, and Oliver [4]. These
studies provided detailed clinical, radiological, and pathological descriptions as well as
documentation ofthe high rate ofasbestosis among textile workers spinning Canadian
chrysotile asbestos.
Theearly 1930s produced a series ofreports regarding theepidemiology and clinical
characteristics ofasbestosis. In 1930, Merewether, then Medical InspectorofFactories
in England, presented a report to Parliament establishing, ". . . the fact that the
inhalation ofasbestos dust over a period ofyears results in thedevelopment of a serious
type offibrosis ofthe lungs" [6,3].
It was suggested by the author that the solution of this problem would be in dust
suppression [3]. Merewether's report is also significant since the author hypothesized
that different forms of fiber may have different biological activities. Subsequently, in
1933 and 1934, Merewether presented mortality data suggesting thatasbestos workers
had shortened life expectancies [4].
Over the next several decades it became apparent that asbestos fibers could be
implicated in the etiology of a number ofdiseases, including lung cancer, mesothelio-
ma, and gastrointestinal cancer. The possible association ofasbestos exposure and the
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development of lung cancer was first proposed in a group of studies published in the
mid-thirties by Gloyne [7,8], Lynch [9], and Nordman [10]. Although cases of
mesothelioma had been described as early as 1870, the first to mention a possible link
to asbestos exposure appears to be an autopsy series published by Wedler in 1943 [11].
Not until 1953 was a large-scale cohort study conducted (among textile workers)
indicating a strong association between occupational exposure and subsequent develop-
ment of mesothelioma [12].
Many regard the 1960s as being the setting for the "awakening" of the scientific and
medical communities to the dangers associated with asbestos exposure. Not only were
studies published regarding disease occurrence in occupational cohorts, but reports
also appeared concerning the possible dangers of environmental exposure [13]. The
intense interest generated by the work of Selikoff and others during this time
culminated in an international conference in New York in 1964 on the biological
effects of asbestos, the proceedings of which were published in 1965 [14].
Since this time the relevant scientific literature has expanded considerably.
Although questions remain, the existing data clearly indicate that asbestos fibers
represent a serious hazard to human health. The challenge that remains is the accurate
determination of the risk posed by such exposure and the institution of a rational and
effective system for its management.
PHYSICAL AND CHEMICAL CHARACTERSTICS
OF ASBESTOS FIBERS
"Asbestos" is a generic term for the fibrous form of a number of mineral silicates.
These substances are found naturally in seams or veins in many igneous or metamor-
phic rocks and belong to one of two groups of rock-forming minerals, i.e., the
serpentines and the amphiboles. The only member of the serpentine group is chrysotile
(or white asbestos), which is by far the most common and commercially the most
important type of asbestos. Ninety to ninety-five percent of all the asbestos used in the
United States is chrysotile mined in Quebec, Canada. When in a vein of ore, chrysotile
appears green and often occurs in the form of soft, flexible, long fibers which can be
spun or woven. Chemically, it is a hydrated magnesium silicate which tends to lose its
magnesium content under acid conditions, making it less desirable than the amphiboles
for certain purposes. Chrysotile fibrils, when examined under electron microscopy, are
shown to be hollow tubes of a variety of curved shapes, which may play a role in
reducing their respirability.
The amphibole group contains crocidolite (blue asbestos), amosite (brown asbestos),
actinolite, anthophyllite, and tremolite. Amosite is an acronym for Asbestos Mines of
South Africa and is mineralogically known as cummingtonite-grunnerite asbestos (a
silicate containing magnesium and iron). It has been used to a larger degree than
chrysotile for insulation under circumstances requiring greater chemical resistance.
The amosite fibril is a solid rectilinear cylinder which is substantially thicker than that
of chrysotile.
Crocidolite or "blue asbestos" is classified mineralogically as a riebeckite mineral,
i.e., a silicate containing iron and sodium. The fibrils of crocidolite are solid rectilinear
cylinders which are shorter, thicker, straighter, and less silky than chrysotile. These
fibers possess a high degree of chemical stability and have found extensive use in areas
requiring this quality, such as in the production of asbestos-cement pipes for
transporting drinking water in cities [15].
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Tremolite, a silicate containing calcium, magnesium, and iron, may occur as a
contaminant in chrysotile and other minerals such as talc. Anthophyllite, although at
one time produced in substantial quantities, is no longer ofcommercial importance.
Two structural properties of amphiboles which lead to fiber production are a
preferred cleavage plane with resistance to cleavage in other planes and structural
defect. Because ofthese properties, amphiboles may be more likely to split into thinner
fibers ofthe same length during factory processing. This aspect ofamphibole structure
may have important biological consequences in regard to pathogenicity [16,17].
Several ofthe important properties which give asbestos its commercial value are its
incombustibility and effectiveness and durability as a binding (or reinforcing) agent
when combined with other materials such as cement or plastic. In general, the different
types are resistant to high temperatures, electric current, and alkalis, and effectively
absorb sound.
Due to the qualities cited above, few commodities have enjoyed the commercial
success which has characterized asbestos over the past 100 years. In 1890 some 1,000
tons were produced, while today annual world production is of the order of six million
tons [18]. The expansion of technologically based society has produced countless
opportunities for new applications of this material. Unfortunately, the ubiquity of
asbestos in modern society represents one ofthe most serious obstacles to its control.
THE BIOLOGICAL EFFECTS OF ASBESTOS
Asbestosis
Parenchymal Asbestosis: Pathology Asbestosis has been described by many
authors as a diffuse interstitial fibrosis. Initially, the pathological characteristics ofthe
disease have few features capable of distinguishing it from that seen in interstitial
fibrosis of other etiology. One of the few, if not only, pathological findings that is
specific is the presence of asbestos fibers in lung tissue, sputum, or bronchial lavage
material, although ifthese are few in number their significance is minimized.
Much of the data concerning the initial pathological changes resulting from
exposure to asbestos comes from animal experiments. In the laboratory setting a
variety of animal species have been exposed to dust by inhalation or intratracheal
injection. Unfortunately, an experimental animal which reacts to asbestos dust in quite
the same manner as man does notexist, which limits thedegree towhich extrapolations
can be made. Nonetheless, animal studies have provided clear evidence that asbestos is
capable of inducing pulmonary fibrosis and a variety ofneoplasms.
The initial effects of asbestos fibers are found in the respiratory bronchioles
following the lodgement of fibers in this tissue. As a result, the bronchioles and their
alveoli develop fibrous thickening of their walls [15]. This condition does not occur
uniformly throughout the lung, and several years or decades must pass before a
sufficient number of respiratory bronchioles and alveoli become affected to produce
clinical evidence ofasbestotic involvement.
The thickening of the walls of the airspaces is due, in large part, to cellular
degeneration with subsequent formation of collagen fibers (scar tissue). The fibrous
collagen is often found between the airspace and its associated capillary wall, which
impairs the exchange of gases between lung and circulatory system. This localized
impairment of gaseous exchange tends to become generalized as the involvement
spreads. Ultimately, the scar tissue causes the walls of the air space to stiffen, thereby
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reducing total lung capacity and decreasing compliance. Over extended periods of
time, the obliteration of capillaries may lead to a reduction in the total size/extent of
the pulmonary capillary bed, which, along with the resulting pulmonary hypertension,
may result in cor pulmonale.
Although pulmonary fibrosis may have various etiologies, the feature that clearly
differentiates asbestosis from other forms of lung fibrosis is the presence of asbestos
bodies. These structures are generally yellow-brown in color and measure about 80
micrometers or more in length and up to 25 micrometers in width. At the core of the
asbestos body is an asbestos fiber. The golden-brown appearance of the body is due to
the coat of iron containing mucoprotein surrounding the fiber. The iron component of
the coat is probably derived from hemoglobin. It is important to note that while their
presence in any quantity in lung tissue is strongly suggestive ofasbestos being the cause
ofany fibrosis present, a small number ofsuch bodies may be found in individuals with
minimal exposure and no clinical or pathological signs ofdisease.
Parenchymal Asbestosis: Physiological and Clinical Manifestations Clinical
symptoms vary with stage of disease and rapidity of development. Although the most
common initial symptom is dyspnea upon exertion, often accompanied bydry cough, it
should be noted that cough appears to be most common among patients who are
cigarette smokers. In the less extensive cases, pain is often absent, although a feeling of
"tightness in the chest" may be present.
The dyspnea usually present progresses even when the patient is removed from
contact with asbestos, resulting eventually in the development of cor pulmonale and
death within 15 years of the onset of disease.. In the later stages of diseases, cough,
sputum production, and loss ofweight are frequently observed, and the patient is often
subject to recurrent respiratory infections.
On physical examination, the most distinctive sign of asbestosis is the presence of
rales. These findings are probably related to abnormal lung deflation and are
indistinguishable from those heard in other forms of pulmonary fibrosis [19].
Wheezing, commonly heard in cases ofsilicosis or coal workers' pneumoconiosis, is not
heard in asbestosis, and indications of massive emphysema are rarely present.
As the disease progresses, other signs may be found, including finger clubbing and
cyanosis. While clubbing is seen fairly commonly in chronic respiratorydisease, among
the pneumoconioses it is not commonly seen in cases of asbestosis [3]. Cyanosis is
indicative of interference with oxygen uptake in advanced pulmonary disease.
Pleural Asbestosis In addition to the lung parenchyma, inhalation ofasbestos dust
is also associated with non-neoplastic changes of the pleura or pleural cavity known as
pleural asbestosis. Pleural asbestosis involves the pulmonary pleura, which is the serous
membrane covering the interior surface of the lung. The parietal pleura lines the inner
chest wall, diaphragm, and middle thorax structures. The changes associated with this
disease entity are pleural thickening, pleural effusion, hyaline plaques, and calcified
plaques.
In cases of marked parenchymal asbestosis, simple thickening of the visceral pleura
is a common finding. It consists of collagenization of the underlying connective tissue
layer (fibrosis), which is indistinguishable from that caused by other agents. As with
parenchymal asbestosis, changes in the visceral pleura are most commonly seen in the
lower two-thirds of the lung.
Pleural effusion has been reported in a number of studies regarding asbestos-related
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disease [19,20,211. This fluid is serofibrous or serohemorrhagic and may appear in the
pleural cavity without producing clinical symptoms. Often, it contains a number of
lymphocytes, erythrocytes, and possibly neutrophils but is sterile and usually rich in
albumin. In most instances, pleural thickening is also present. Asbestos bodies are
rarely found in the fluid, although they are generally present in the underlying
parenchyma [22].
A pleural plaque is a localized fibrous thickening ofa parietal pleural surface. They
are often bilateral and symmetrical, occurring along the lower ribs or on the central
tendon of the diaphragm.
The term plaque may refer to a substantial pleural thickening or to a hyaline or
calcified plaque. Hyaline plaques are whitish raised areas of collagen fibers with
sharply defined margins. They may appear on both visceral and parietal pleura but
much more commonly on the latter. Calcified plaques have a more opaque white or
ivory color and are mineralized thickenings found more commonly on the parietal than
visceral pleura.
The presence ofpleural plaques is usually associated with exposure to asbestos, talc,
or mica, although the biological mechanisms responsible for their production are
poorly understood. When pleural plaques are present, lung function may be reduced to
some degree even though other symptoms of pathology may be absent. Controversy
currently exists regarding the association ofpleural plaques and various carcinomas as
well as other diseases. Nonetheless, their presence is suggestive ofexposure to asbestos
fibers either by inhalation or ingestion [23].
Epidemiology ofAsbestosis Morbidity studies using various occupational cohorts
have provided the medical practitioner and epidemiologist with strong evidence of the
ability ofasbestos fibers to induce fibrotic lung disease in chronically exposed humans.
One major drawback of these data is the limited information provided concerning the
demographic, physiological, and exposure characteristics of the exposed population
from which cases were drawn, i.e., the population at risk. From a public health
standpoint, this information would be ofvalue in estimating the expected prevalence of
this disease among previously or currently exposed individuals. Without this informa-
tion, it is not possible to assess the impact ofasbestos exposure on overall mortality and
morbidity due to fibrotic lung disease among the exposed population.
An additional limitation ofthe data currently available is the possible underestima-
tion ofthe number ofindividuals actually exposed, i.e., at risk ofdeveloping asbestosis.
In the past such groups as maintenance and clerical workers were not regarded as
being at risk, while today evidence to the contrary exists. Nonetheless, the medical
literature, despite its limitations, gives one at least a general impression of the
prevalence ofthe asbestoses in a variety ofoccupational cohorts.
Data derived from occupational cohorts ofasbestos miners and millers, although not
extensive, consistently show a marked increase in pulmonary fibrosis with cumulative
duration of exposure. In 1972, McDonald et al. [24] reported the results of a
cross-sectional study involving chrysotile asbestos miners and mill workers in Quebec,
Canada. Among the 1,015 study subjects, shortness ofbreath was observed to increase
with estimated cumulative dust exposure. Two measures oflung function, FVC (forced
vital capacity) and FEV1 (forced expiratory volume in one second) were found to
decrease with estimated cumulative dust exposure in smokers and non-smokers.
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McDonald et al., in a 1974 mortality study [25] of chrysotile miners and millers,
observed increased mortality among individuals with parenchymal changes but not in
those having only pleural changes. Among the study group of 5,083 employees, 32
deaths due to all respiratory diseases were recorded although only eight were expected,
based on general population mortality data.
In a cohort of 485 miners and millers, Selikoff reported the prevalence of
radiographic abnormalities to be 10 percent with pleural changes seen in 3 percent of
all workers [4]. The prevalence of abnormalities among those employed less than five
years was 5 percent.
Irwig et al. in 1979 published the results ofa study of 1,801 crocidolite and amosite
miners [26] showing that the prevalence ofpleural changes increased from 2.5 percent
for workers with less than one year of employment to 33.6 percent for workers
employed 15 years or more. Parenchymal changeswere found in 2.3 percent ofworkers
employed less than one year and 25.7 percent of workers employed more than 15
years.
Textile workers constitute an additional occupational group from which a variety of
epidemiological data have been derived. In 1968, using results of a study of 290 such
workers, the British Occupational Hygiene Society estimated the risk of developing
pulmonary disease for a working lifetime of 50 years to be 1 percent at an exposure
level oftwo fibers per cubic centimeter [27].
In reviewing the prevalence of pulmonary fibrosis among 1,287 asbestos textile
workers, Lewinsohn in 1972 reported zero prevalence for 0-9 years of exposure,
increasing to 40.5 percent after 30-39 years of exposure. Pleural fibrosis prevalence
was 1.6 percent in the 0-9 years' exposure group and 50 percent in the 40-49-year
category [28].
Weiss in 1971 examined an occupational cohort of 100 textile workers [29]. The
overall prevalence offibrosis was 36 percent; 24 percent in non-smokers and 40 percent
in smokers. None ofthe 11 non-smokers in this study with exposures less than 20 years
had fibrosis.
In a cohort of611 New Jersey asbestos factory employees, who in 1959 had passed
20 years or more since initial exposure, Nicholson reported 213 deaths from all causes
over the period 1959-1973 [3]. Twenty-three, or 10.8 percent, were attributed to
asbestosis, 14.1 percent to lung cancer, and 8.5 percent to mesothelioma.
A number ofconclusions regarding asbestosis can be drawn from the data available
in the medical literature. Ten to 20 years ago, dust levels in the industrial setting were
generally much higher than today; therefore, a high incidence of asbestosis can be
expected among those exposed for more than ten years during this time. This incidence
rate may approach 50 percent for those exposed for more than 20 years. With the
improvement in working conditions, it is expected that the number of new cases will
declineand that a longer time will elapse before thedisease becomes radiologically and
clinically detectable. This situation may be particularly true for parenchymal fibrosis,
since as exposure levels fall, pleural rather than parenchymal changes become more
common.
Lung Cancer
Background Information Among the countries of Western Europe and North
America, lung cancer is theleading form ofcancer, with annual age-adjusted incidence
rates among males exceeding 11 per 100,000 population in Great Britain and U.S.
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blacks [30]. In the United States primary lung cancer accounts for 15 percent of all
cancer cases and 25 percent of all cancer deaths. These statistics clearly demonstrate
the high fatality rate experienced among lung cancer patients.
A variety of epidemiological, clinical, and laboratory studies have identified
cigarette smoking as the predominant risk factor, with industrial exposure also playing
an important role. Because of the feasibility ofexternal manipulation of these factors,
lung cancer is largely a preventable disease.
As with asbestosis, epidemiological evidence indicates that lung cancer risk is
substantially raised among various asbestos industry employees, including miners and
millers, textile and shipyard workers [31,32]. In fact, it is the major asbestos-related
disease, accounting for a high proportion of all deaths in many exposed cohorts [33].
Although the medical literature of the 1930s and 1940s contains reports of an
association between lung cancer and asbestos exposure [7,8,34,35], the first epidemio-
logical investigation ofthis association was published by Doll in 1955 [12]. Two groups
of subjects were examined. The first group was composed of 105 persons employed in
an asbestos textile factory in northern England on whom autopsies were performed.
Lung cancer was found in 18 instances, 15 times in association with asbestosis.
In addition, 13 men who had worked for at least 20 years in the same textile factory
were followed up and their mortality experience compared with that which would have
been expected on the basis of the mortality experience of the entire male population.
There were 11 observed lung cancerdeaths, compared to a calculatedexpected number
of 0.8. This indicated that the risk ofdeveloping lung cancer in that factory during the
time studied was 13.75 times that of the general population. All cases of lung cancer
were confirmed histologically and were associated with asbestosis.
This same cohort was subsequently followed up by a number of investigators
[36,37,38]. By 1957, dust levels in this factory were reduced by 50 percent to 80
percent of their 1955 value. The 1951 mean dust level was 10.8 fibers per cubic
centimeter while the 1972 mean dust level was calculated to be 2.9 fibers per cubic
centimeter. The lung cancer data presented indicated that the risk ofdeveloping lung
cancer by the end of 1972 was 2.1 times that ofthegeneral population ofEngland and
Wales.
A 1980 study by Peto [38] once again compared the mortality experience of this
occupational cohort. The 567 men entered in this analysis were subdivided into three
groups. Group 1 was composed of 69 men with more than 20 years of asbestos
exposure, more than ten of these years being before 1933 when dust reduction efforts
became mandatory. Group 2 contained the data from 74 men with greater than 20
years' exposure with less than ten years' exposure before 1933, while Group 3 included
434 men having less than ten years of exposure between 1933 and 1950. The ratio of
observed to expected number ofdeaths due to lung cancer in the three subgroups was
8.1, 2.0, and 1.6, respectively, indicating an association between death from lung
cancer and increased exposure level.
Finkelstein [39], in 1983, published the results of a study conducted among 328
employees ofan Ontario asbestos cement factory hired before 1960 andemployed for a
minimum of nine years. Both chrysotile and crocidolite asbestos were used in the
manufacturing process. Twenty deaths due to lung cancer were observed, while the
calculated expected number was 3.3, representing a sixfold increase in risk for lung
cancer among the exposed population (death rates for the Province of Ontario were
used to compute expected number ofdeaths).
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Since the mid-1960s, a plethora of articles has appeared on the association of lung
cancer with asbestos exposure, particularly in relation to occurrence of disease under
various exposure conditions (i.e., dust concentration, various occupational settings, and
so on). The appearance ofthese reports has led to the identification and exploration of
a number of controversial areas: the effects of cigarette smoking, the association
between type of fiber exposure and disease, peak vs. continuous exposure, dose-
response relationship, and physical dimension of fibers as an indicator ofcarcinogenic
potential [40,41,42,43,44]. The following will be a brief discussion of these topics
based upon currently available data.
Dose-Response RelationshipforAsbestos and Lung Cancer Although the existing
data are consistent with the hypothesis that excess mortality from lung cancer
following a fixed duration of exposure is proportional to airborne concentration of
asbestos and that mortality increases with increasing duration of exposure, the poor
quality of past exposure measurements severely limits quantification of this observa-
tion. Bearing this caveat in mind, three recent reportscomparing lung cancermortality
to total exposure level ofasbestos suggest the existence of a linear relationship between
these quantities [45,46,47]. While all showed that respiratory cancer risk increased as
exposure level increased, the numbers of cases in these reports are relatively small,
making it difficult to specify accurately the shape of the exposure intensity-response
curve after adjustment for duration of exposure.
Differences in Mortality Between Fiber Types The evidence for differences in the
potential for inducing lung cancer among the various asbestos fiber types is mixed and
inconclusive, although it is generally believed that crocidolite is biologically more
active than chrysotile and that amosite occupies an intermediate position. Two studies
provide support for this contention. The first [48] concerned 1,348 men from the
asbestos industry who had retired during the years 1941 through 1967. The pertinent
data comprised deaths that had occurred among these retirees through 1969. In
addition to the observation of increased risk ofdeath due to lung cancer in relation to
asbestos exposure, individuals exposed tochrysotile alone experienced a death rate due
to lung cancer that was 2.5 times greater than that observed among the general U.S.
male population, while those exposed to both chrysotile and crocidolite had a mortality
rate five times that of the general U.S. male population.
In the second study [49] a cohort of 5,645 white and black male workers was
investigated. These men had been employed for at least one continuous month before
January 1, 1970, in either one oftwo asbestos-cement building materials plants in New
Orleans, Louisiana. All had their initial employment 20 years previously and had been
followed through 1974. After stratifying subjects according to cumulative exposure, it
was found that, among those in the most heavily exposed category, those exposed to
dust containing both chrysotile and crocidolite had a higher level of excess mortality
than those exposed to dust containing only chrysotile.
Clearly, several problems remain concerning the carcinogenic potential ofdifferent
fiber types. One of the most important is the apparent scarcity for study of
occupational cohorts exposed to a single fiber type over considerable time periods.
Also, exposure data is often inaccurate or not available. Although animal experiments
have supported the theory of differing carcinogenic potentials, extrapolations from
animal systems to humans may not be appropriate due to differences in physiology,
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routes of entry of fibers, and fiber exposure level. Data derived from this source must
therefore be considered cautiously.
Relation ofFiber Size to Cancer Development The influence of fiber size on tissue
response and the production of cancer has been decisively demonstrated experimen-
tally by the failure of short fibers to cause disease [50,51]1. Similarly, epidemiological
studies have shown that the inhalation of short asbestos fibers has not caused an
increased risk of death from non-malignant respiratory disease. With regard to lung
cancer, the epidemiological evidence remains equivocal [15] to the extent that no firm
conclusion can be drawn about this relationship based upon present information.
Even though long fibers are indisputably fibrogenic, a level cannot be specified
below which fibrogenicity approaches zero. Adequate information is simply lacking
regarding the movement and ultimate pathogenic action ofthose fibers observable only
by electron microscopy [3].
Effects ofCigarette Smoking In the vast majority of studies of asbestos workers,
information on smoking habits is absent. Selikoff, Hammond, and Churg, in 1968,
were the first to publish a report on the effects ofsmoking on the incidence ofasbestotic
lung cancer [3]. It was found that asbestos workers who smoked had eight times the
lung cancer risk ofall other smokers and 92 times the risk ofnon-smokers who did work
with asbestos. Based upon follow-up data from this study, it has been hypothesized that
these carcinogens (asbestos and cigarette smoke) react synergistically to produce very
high lung cancer rates among those exposed to both substances, while the risk among
those exposed to either substance alone is significantly lower.
Summary Since the publication of Doll's 1955 study, evidence has accumulated
clearly establishing that occupational exposure to asbestos substantially increases the
risk of pulmonary carcinoma. As indicated earlier, cigarette smoking is perhaps the
most important factor in the production of this increased risk. Although asbestos has
relatively weak carcinogenic properties itself, this potential could be raised to effective
levels ifthe dose is high, but with high doses pulmonary fibrosis becomes a likely cause
of mortality, precluding the development of lung cancer. Nonetheless, it appears that
asbestos can augment the effects of other potent carcinogens, such as cigarette smoke,
producing a greatly increased risk of pulmonary cancer among those exposed to both
substances [3].
With the institution of measures to reduce exposure levels in the workplace,
pulmonary carcinoma is seen with increasing frequency, since early deaths due to
asbestosis and other respiratory insufficiencies are less likely at lower dosages. In the
early part of this century, asbestosis was an early killer and only those that avoided
death due to this cause lived long enough to acquire lung cancer or mesothelioma.
Today, bronchogenic carcinoma, followed by mesothelioma, is responsible for the early
death of a large number of exposed individuals. Only the survivors from these diseases
are open to later lethal effects of the now more slowly developing asbestosis. Over the
next several decades, late deaths due to asbestosis may well decline due to dust control
measures put in place in previous years. Unfortunately, it is unlikely that deaths due to
asbestos-associated lung cancer will show a substantial reduction in the near future.
Mesothelioma
Definition and Character A number of issues have hindered the recognition of
diffuse malignant mesothelioma by the medical community as a distinct pathological
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entity. Among these are the rarity of the tumor in the early part of this century; the
occurrence of what are apparently two forms of this tumor, i.e., the localized and
benign versus the diffuse and malignant; and the possibility that an apparently primary
tumor of the mesothelium may actually be a secondary growth from a primary tumor
located in a different anatomical site [3]. Over the last 40 years two important
developments have contributed to this tumor's recognition and characterization:
namely, its increased prevalence and implication of asbestos as an etiological factor
[52]. By 1960, therefore, publication of detailed descriptions of the diagnostic details
of malignant mesothelioma allowed for the standardization of diagnostic criteria and
the acceptance of mesothelioma as a clinical entity [53].
Today, mesothelioma is characterized as a highly malignant cancer that originates
in the lining of the chest or abdominal cavity. In almost all instances it is rapidly fatal,
with median survival times averaging two to 18 months from diagnosis. More recently,
selected patients treated initially with surgery, radiotherapy, and chemotherapy have
achieved a longer median survival, with occasional patients disease-free at five years.
Until the publication of a report by Wagner et al. in 1960 [13], describing 33 cases
of diffuse pleural mesothelioma in South Africa, this tumor was considered a rare
clinical entity. Since then, the relevant medical literature has expanded substantially
and currently includes case reports and epidemiological studies describing the
increased occurrence of mesothelioma in specific occupational cohorts as well as in
domestic and environmental settings.
Apart from its previous rarity, this cancer is also unusual histologically in that it is
composed of cells capable of forming either adenocarcinoma or sarcoma or a mixture
ofthe two [15]. In pleural mesothelioma, both the parietal and visceral pleura may be
involved, with the parietal surface usually more extensively affected. Ultimately, the
tumor spreads, covering the surface of the lung with dense, white, and often leathery
tissue with little penetration of the lung parenchyma, although massive invasion
occasionally occurs. Compression of the lung follows, with partial or total obliteration
ofthe pleural cavity.
In the peritoneum, the tumor covers the intestines and tends to bind them together.
Obliteration ofthe peritoneal cavity with incorporation ofall viscera in the tumor mass
may occur. Although mesotheliomas do metastasize, this condition is not common
except for the involvement of regional lymph nodes. More distant metastases may
appear in the liver, lung, and, to a lesser degree, in the spleen and bone [15].
Microscopically, malignant mesothelioma occurs in three forms; epithelial, mixed,
or sarcomatoid in order of decreasing frequency [3]. Variability of histological
structure, even within a single tumor, is characteristic of mesothelioma. In the purely
epithelial form, the tumor forms glandular patterns and resembles an adenocarcinoma.
The fibrous form of mesothelioma closely resembles a sarcoma, while the mixed type
may show a variety of appearances and for that reason is very suggestive of
mesothelioma.
Incidence and Epidemiological Characteristics As stated earlier, Wagner first
drew attention to this tumor in 1960 in a report of 33 patients with mesothelioma in
South Africa. Based upon occupational and residential histories, it was discovered that
all but one had either worked in the crocidolite asbestos mines in the Cape Province,
had handled asbestos in some capacity (e.g., transport of asbestos materials), or had
lived near the mines. In this series both men and women were affected, with all patients
dying of pleural tumors.
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In 1964, Newhouse conducted a case-control study of patients dying of mesothe-
lioma at the London Hospital [54]. All cases of mesothelioma occurring since 1969
were reviewed and the diagnosis was confirmed in 83 cases (41 men and 42 women).
Occupational and residential exposure histories were obtained from surviving relatives
and revealed that 52.6 percent had had a positive history of asbestos exposure. Of
particular interest is the fact that 11 patients had neither a history ofoccupational nor
household exposure, but had lived in theimmediatevicinityofan asbestosfactory. This
study also provided evidence that domestic contact from dust brought home on clothes
was important in the pathogenesis ofmesothelioma.
A disturbing feature ofmany reports concerning cases ofthis tumor is that patients
may give histories of short and apparently low-level exposures [55,56,57,58]. It must
be remembered though that occupational and residential histories are often obtained
decades after exposure may have occurred and that poor recall may play a role.
Exposure may thus have been heavier than realized.
A summary of 22 countries indicated that a total of4,539 malignant mesotheliomas
were reported between 1959 and 1976 [15]. Since some of the mesothelioma deaths
may not have been recognized, this total may represent an underestimate. A more
recent study of the incidence of malignant mesothelioma in North America between
1960 and 1975 showed that there were 272 deaths from mesothelioma in the United
States and 396 deaths from this tumor in Canada [59]. From this data, the annual
incidence of mesothelioma in North America was estimated at 2.8 per million males
and 0.7 per million females age 15 years and older.
The medical literature of the last ten years reflects the growing interest and
heightened awareness surrounding malignant mesothelioma within the medical com-
munity. Many of these studies address the more controversial issues relating to this
tumor, including the influence ofdust concentration on thedevelopment ofmesothelio-
ma, the influence of duration of exposure on incidence, and the etiologic role of
different fiber types. While the relationship between duration and level of exposure
and the development of malignant mesothelioma remains unclear, epidemiological
studies ofoccupational cohorts strongly suggest the existence ofa gradient in potential
potency to induce mesothelioma among different fiber types.
McDonald et al. in 1978 traced 199 persons exposed tocrocidolite between 1939 and
1942 in three Canadian factories. Comparison of the mortality pattern within this
group with that observed in the Quebec chrysotile mining and milling industry
indicated that mesothelioma was some 60 times more frequent in the crocidolite- than
in the chrysotile-exposed cohort [60]. There was also a major difference in the site of
the mesothelial tumors; in the crocidolite cohort, six of the nine cases involved the
peritoneum compared with only one of the 11 in the chrysotile cohort. The authors
ascribe this difference in mortality to the fiber type. Similarly, Wignal and Fox in a
1981 report [44] observed a substantial excess risk ofmesothelioma among a cohort of
female gas mask assemblers exposed to relatively high levels of crocidolite. Thus, the
epidemiological and experimental evidence suggest that there is a gradient from
crocidolite to chrysotile asbestos in their potential potency to induce mesothelioma,
with amosite occupying an intermediate position.
Latency Period Following the recognition of an association between asbestos
exposure and the occurrence of mesothelioma, it became clear that the interval
between initial exposure and the onset ofdisease is long, usually 35 years or more. Data
from epidemiological studies indicate that at less than 30 years from initial exposure
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only 20 percent of the total mesothelioma deaths in an exposed cohort will have taken
place [15]. The existence of this latency period does not mean that the malignancy is
established early on and grows slowly but rather that the transformation of normal
cells to cancerous ones requires many years.
Curiously, a careful review of the available literature will reveal the existence of
reports directly contradicting the above information. Cases ofmesothelioma have been
reported (although rarely) to occur after very short periods since first exposure [42] as
well as in children in whom occupational exposuredoes not play a role [61]. In thecase
ofworkers, incorrect/inadequate occupational histories might provide an explanation,
but in children it is most likely that some pathogenic mechanism other than asbestos is
operative. This mechanism may be identical to that responsible for the sporadic cases
ofmesothelioma reported before asbestos was a significant public health hazard.
Conclusion Studies from many areas of the world indicate that the incidence of
mesothelioma is rising, with some of the highest rates occurring in the United States,
Germany, the Netherlands, and England [3]. Undoubtedly, this rising incidence isdue
to the rapid expansion of the asbestos industry and the increased use of asbestos
products throughout this century. Unfortunately, widespread substitution of other
material for asbestos has not occurred, contributing to the persistence ofthis hazard.
Because ofthe long latent period between exposure and development ofmesothelio-
ma, those individuals exposed during the 1940s are only now beginning to develop
clinical disease. Projections based upon information derived from epidemiological
studies predict that the number of deaths due to mesothelioma will continue to rise
among asbestos workers such as those who worked in shipyards and asbestos factories
[62]. This increase is expected to continue throughout the 1980s.
Gastrointestinal Cancer
Information concerning the possible relationship between asbestos and cancers of
the buccal cavity, esophagus, stomach, colon, and rectum is derived largely from
studies of occupational cohorts, although the incidence of gastrointestinal cancer has
also been examined in non-occupational settings with known asbestos contamination.
The total amount ofevidence available, however, is meager, making the elucidation of
a possible causal relationship difficult. In addition, the number ofanimal experiments
reported is small and the experimental designs have generally been poor. Therefore,
controversy still exists regarding this disease-exposure relationship.
In 1979, Selikoff et al. [63] published the results of a study of U.S. and Canadian
insulation workers experiencing the largest number of asbestos-related deaths among
any group ofasbestos workers examined. The mortality of 17,800 asbestos workers was
studied prospectively from January 1, 1967, through December 31, 1976. Overall,
2,271 deaths occurred with 120 due to gastrointestinal cancers. Based upon white male
age-specific U.S. death rates for this period, only 69.5 were expected; a significant,
although small, increase in mortality.
Elmes and Simpson, in 1977 [64], reports the results of a follow-up study of 170
insulators and pipe coverers in Belfast, Northern Ireland. Expected deaths were
derived from death rates for Northern Ireland, giving a ratio of observed to expected
deaths from gastrointestinal cancer of 5:9.
In a study of London asbestos factory workers who had been exposed to crocidolite,
amosite, and chrysotile, (4,600 men, 972 women) no statistically significant excess in
gastrointestinal (GI) cancer deaths was observed among those with low to moderate
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exposure. Both men and women with "high"-level exposure showed a significant excess
of cancer deaths due to GI malignancies [33]. Gross and Braun summarize the
epidemiological data based on occupational exposures as follows;
There has been an increased incidence ofgastrointestinal cancers among some
asbestos workers and among miners exposed to elongated amphibole crystals.
This increased incidence has not been large and has been largely limited to
those most heavily exposed. It has also been more pronounced in cigarette
smokers. There are also investigations which failed to find any association
between asbestos dust exposure and gastrointestinal cancer... [15].
It is therefore clear that the association of gastrointestinal cancer with asbestos
exposure in the occupational environment is weak. Further epidemiological studies are
necessary to define the relative risk accurately and clearly establish the possible
influence ofother factors in the etiology ofthese tumors.
EXPERIMENTAL STUDIES
The useful aspect ofthe majority ofanimal studies conducted to examine the health
effects of asbestos has been their confirmation of previously established human data.
They have also served to elucidate more fully the pathological mechanisms ofasbestos
fibers on specific organ systems. The ability ofanimal studies to predict human disease
is limited by the relative resistance of some animal models to the human disease of
concern; the uncertainty inherent in procedures used to extrapolate from experimental
systems to estimate the possibility of the occurrence of similar effects in humans; and
bythefact that lung cancer, theprincipal carcinogenic riskfromasbestos, "isthe result
of a multifactorial interaction of causal agents, i.e., cigarette smoking and asbestos
exposure, and is difficult to elicit in a single exposurecircumstance" [65]. Nonetheless,
animal studies have provided important information not available from human studies,
such as data on the deposition and clearance offibers as well as cytotoxicity.
Among the major findings to emerge from the laboratory is the demonstration that
mesothelioma and lung cancer can be produced by all the major commercial types of
asbestos: i.e., chrysotile, amosite, crocidolite, and anthophylite [66,6t]. Studies
examining the deposition and clearance of fibers from the respiratory system of test
animals suggest that the majority (approximately 99 percent) of inhaled fibers are
eventually cleared from the lung by ciliary or phagocytic action. Of all fiber types,
chrysotile appears to be most readily removed.
Implantation and injection studies show that the carcinogenicity ofmineral fibers is
directly related to their dimensionality and not their chemical composition [65,51,50].
Particles with dimensional aspect ratios of 3:1 or greater, longer than 4 micrometers,
and thinner than 1 micrometer are most carcinogenic; however, deposition clearance
and migration offibers are also size-dependent. Therefore, these factors may also play
an important role in carcinogenicity. Unfortunately, the interplay of all these
size-dependent effects is poorly understood.
UNRESOLVED ISSUES
One of the more perplexing and technologically difficult questions to address in
relation to asbestos-associated disease is the risk posed by low-level exposure. This
issue is important because ofthe huge amounts ofasbestos materials incorporated into
buildings worldwide. Often, these materials are friable and are capable of being
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released into the indoor environment, posing a health risk to those coming in contact
with these airborne fibers. In the industrial setting, engineering control measures are
capable oflimiting exposure to extremely low levels in certain operations, although this
is not the case in all industrial processes.
Current knowledge of the risks associated with low-level exposure relies on
downward extrapolation from findings associated with high-level exposure. The
uncertainty inherent in this process is considerable, severely limiting estimates derived
by this process. Unfortunately, more satisfactory mathematical models have not been
developed, making accurate predictions concerning the occurrence ofexcess disease at
low exposure levels unattainable. Also, with the current work force experiencing
substantially lower exposures than their counterparts in the earlier part ofthe century,
the "latent periods" ofthe asbestos-associated diseases may be increased. The severity
of these clinical manifestations may also be reduced. Both of these factors may
complicate epidemiological analyses.
An issue closely related to the "dose-response" question, and largely ignored in the
medical literature, is that of individual susceptibility (given comparable exposure to
risk factors). Although studies of the immunological status of patients with asbestos-
related diseases have been conducted, they are few in number and therefore the
available data are sparse. Because an understanding of the interplay of factors
affecting individual susceptibility may provide the basis for disease prevention
strategies and long-range projections ofmortality and morbidity, new methods in study
design and analysis should be developed to address this question.
As described throughout this paper, a number of etiologic issues remain unsolved:
namely, the mechanisms responsible for production of disease in the pleura (both
visceral and parietal) and lung parenchyma, the apparent existence of a gradient in
biological effects among fiber types, and the ability of asbestos to induce airway
dysfunction [68]. Solution of these problems will not only provide information
regarding specific pathological processes but may also have practical implications in
the reduction ofmortality and morbidity due to asbestos-related diseases.
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